VENETOCLAX (VEN), BENDAMUSTINE (B) AND RITUXIMAB (R) IN PATIENTS (PTS) WITH RELAPSED OR REFRACTORY (R/R) NON-HODGKIN LYMPHOMA (NHL): FINAL RESULTS OF a PHASE I STUDYLode J. Swinnen,Christopher R. Flowers,Ding Wang,Erin Reid,Nathan Fowler,Jaclyn Cordero,Martin Dunbar,Sari H. Enschede,C. Nolan,A.M. Petrich,J. Ross,Ahmed Hamed Salem, M. Verdugo,Shekman Wong, L. Zhou,Mark Kozloff,L. Nastoupil,S. de VosHematological Oncology（2017）引用 4|浏览48暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
